This Veterinary Stereotactic Radiosurgery System report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The veterinary stereotactic radiosurgery system market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing pet ownership, veterinary healthcare investments, regulatory support, growing pet insurance.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to expanding geriatric pet population, rising awareness and education, globalization of veterinary services. Major trends in the forecast period include integration of ai and robotics, continuous technological innovation, increased focus on personalized medicine, telemedicine integration, collaborations and partnerships, growing popularity of cyberknife and linac systems, focus on minimally invasive procedures.
The growth of the veterinary stereotactic radiosurgery system market is anticipated to be driven by the increasing pet population. Pets, referring to animals kept in homes for enjoyment and companionship, can benefit from the veterinary stereotactic radiosurgery system, which aids in treating tumors in pets with diverse head sizes and shapes. According to the People's Dispensary Sick Animals wellness (PAW) Report, the UK's largest annual examination of pet wellness, 53% of UK adults are projected to own a pet in 2023, showcasing an increase from 51% in February 2020. Among them, 29% own a dog, 24% own a cat, and 2% own a rabbit. The veterinary practitioners report a 67% increase in the pet population over the last two years, with 71% attributing it to more pets in their clinics and 54% to an increase in new pets in their communities. Therefore, the surge in the pet population is a significant driver of the veterinary stereotactic radiosurgery system market.
An increase in pet health awareness is anticipated to drive the growth of the veterinary stereotactic radiosurgery system market in the future. Pet health awareness refers to the understanding and knowledge that pet owners have regarding their pets' health requirements and the importance of preventive care. As pet owners become more conscious of their pets' health needs and the benefits of preventive treatments, they are increasingly choosing advanced treatment options such as stereotactic radiosurgery. For example, in 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced that it would allocate over $16.3 million to 64 projects in collaboration with states, universities, and other partners to enhance programs aimed at safeguarding animal health. Consequently, the rise in pet health awareness is propelling the growth of the veterinary stereotactic radiosurgery system market.
Technological advancements represent a prominent trend in the veterinary stereotactic radiosurgery system market. Key players are actively developing advanced technologies to maintain their position in the market. For example, Accuray Incorporated, a U. S. -based manufacturer of radiotherapy systems, introduced the CyberKnife S7 system, the latest iteration of its CyberKnife radiation therapy platform. Leveraging robotic radiation therapy, the S7 system administers stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments within a 15-minute timeframe. It addresses neurological diseases, benign, and malignant cancers across the body. The system utilizes Accuray's Synchrony motion-synchronization technology to tailor radiation administration in real-time based on patient and/or tumor movement. The unique robotic architecture allows radiation delivery from numerous angles.
In October 2022, Aspen Surgical Products Inc., a U. S. -based full-service veterinary hospital, acquired Symmetry Surgical, enhancing its portfolio and commercial capabilities. Symmetry Surgical, a U. S. -based provider of surgical instrumentation and solutions, adds clinically favored products to Aspen's portfolio, enabling diversification into more desirable adjacent categories.
In June 2022, Telix Pharmaceuticals Limited, an Australian biotechnology firm, partnered with RefleXion Medical Inc. The collaboration aims to develop 68Ga PSMA-PET imaging agents for use with BgRT, potentially extending this exclusive partnership beyond the U.S. to aid in the regulatory approval of Illuccix and improve the detection and treatment of metastatic disease. RefleXion Medical Inc. is a U.S.-based medical device company that specializes in innovative cancer therapies and offers a veterinary stereotactic radiosurgery system.
Major companies operating in the veterinary stereotactic radiosurgery system market include PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., Nanovi Radiotherapy A/S, Ion Beam Applications SA, ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Hitachi Ltd., Sumitomo Heavy Industries Ltd., Shinva Medical Instrument Co. Ltd., Beijing Wandong Medical Equipment Co. Ltd., Neusoft Medical Systems Co. Ltd., Xinjiang Xinxing Medical Equipment Co. Ltd., Beijing Neusoft Medical Systems Co. Ltd., Siemens Healthineers AG, Philips Healthcare Company, GE Healthcare Technologies Inc., Toshiba Medical Systems Corporation, Hitachi Aloka Medical Ltd., Vision RT Limited.
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2024. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The veterinary stereotactic radiosurgery system market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing pet ownership, veterinary healthcare investments, regulatory support, growing pet insurance.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to expanding geriatric pet population, rising awareness and education, globalization of veterinary services. Major trends in the forecast period include integration of ai and robotics, continuous technological innovation, increased focus on personalized medicine, telemedicine integration, collaborations and partnerships, growing popularity of cyberknife and linac systems, focus on minimally invasive procedures.
The growth of the veterinary stereotactic radiosurgery system market is anticipated to be driven by the increasing pet population. Pets, referring to animals kept in homes for enjoyment and companionship, can benefit from the veterinary stereotactic radiosurgery system, which aids in treating tumors in pets with diverse head sizes and shapes. According to the People's Dispensary Sick Animals wellness (PAW) Report, the UK's largest annual examination of pet wellness, 53% of UK adults are projected to own a pet in 2023, showcasing an increase from 51% in February 2020. Among them, 29% own a dog, 24% own a cat, and 2% own a rabbit. The veterinary practitioners report a 67% increase in the pet population over the last two years, with 71% attributing it to more pets in their clinics and 54% to an increase in new pets in their communities. Therefore, the surge in the pet population is a significant driver of the veterinary stereotactic radiosurgery system market.
An increase in pet health awareness is anticipated to drive the growth of the veterinary stereotactic radiosurgery system market in the future. Pet health awareness refers to the understanding and knowledge that pet owners have regarding their pets' health requirements and the importance of preventive care. As pet owners become more conscious of their pets' health needs and the benefits of preventive treatments, they are increasingly choosing advanced treatment options such as stereotactic radiosurgery. For example, in 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced that it would allocate over $16.3 million to 64 projects in collaboration with states, universities, and other partners to enhance programs aimed at safeguarding animal health. Consequently, the rise in pet health awareness is propelling the growth of the veterinary stereotactic radiosurgery system market.
Technological advancements represent a prominent trend in the veterinary stereotactic radiosurgery system market. Key players are actively developing advanced technologies to maintain their position in the market. For example, Accuray Incorporated, a U. S. -based manufacturer of radiotherapy systems, introduced the CyberKnife S7 system, the latest iteration of its CyberKnife radiation therapy platform. Leveraging robotic radiation therapy, the S7 system administers stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments within a 15-minute timeframe. It addresses neurological diseases, benign, and malignant cancers across the body. The system utilizes Accuray's Synchrony motion-synchronization technology to tailor radiation administration in real-time based on patient and/or tumor movement. The unique robotic architecture allows radiation delivery from numerous angles.
In October 2022, Aspen Surgical Products Inc., a U. S. -based full-service veterinary hospital, acquired Symmetry Surgical, enhancing its portfolio and commercial capabilities. Symmetry Surgical, a U. S. -based provider of surgical instrumentation and solutions, adds clinically favored products to Aspen's portfolio, enabling diversification into more desirable adjacent categories.
In June 2022, Telix Pharmaceuticals Limited, an Australian biotechnology firm, partnered with RefleXion Medical Inc. The collaboration aims to develop 68Ga PSMA-PET imaging agents for use with BgRT, potentially extending this exclusive partnership beyond the U.S. to aid in the regulatory approval of Illuccix and improve the detection and treatment of metastatic disease. RefleXion Medical Inc. is a U.S.-based medical device company that specializes in innovative cancer therapies and offers a veterinary stereotactic radiosurgery system.
Major companies operating in the veterinary stereotactic radiosurgery system market include PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., Nanovi Radiotherapy A/S, Ion Beam Applications SA, ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Hitachi Ltd., Sumitomo Heavy Industries Ltd., Shinva Medical Instrument Co. Ltd., Beijing Wandong Medical Equipment Co. Ltd., Neusoft Medical Systems Co. Ltd., Xinjiang Xinxing Medical Equipment Co. Ltd., Beijing Neusoft Medical Systems Co. Ltd., Siemens Healthineers AG, Philips Healthcare Company, GE Healthcare Technologies Inc., Toshiba Medical Systems Corporation, Hitachi Aloka Medical Ltd., Vision RT Limited.
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2024. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Veterinary Stereotactic Radiosurgery System Market Characteristics3. Veterinary Stereotactic Radiosurgery System Market Trends and Strategies4. Veterinary Stereotactic Radiosurgery System Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Veterinary Stereotactic Radiosurgery System Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Veterinary Stereotactic Radiosurgery System Market34. Recent Developments in the Veterinary Stereotactic Radiosurgery System Market
5. Global Veterinary Stereotactic Radiosurgery System Growth Analysis and Strategic Analysis Framework
6. Veterinary Stereotactic Radiosurgery System Market Segmentation
7. Veterinary Stereotactic Radiosurgery System Market Regional and Country Analysis
8. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market
9. China Veterinary Stereotactic Radiosurgery System Market
10. India Veterinary Stereotactic Radiosurgery System Market
11. Japan Veterinary Stereotactic Radiosurgery System Market
12. Australia Veterinary Stereotactic Radiosurgery System Market
13. Indonesia Veterinary Stereotactic Radiosurgery System Market
14. South Korea Veterinary Stereotactic Radiosurgery System Market
15. Western Europe Veterinary Stereotactic Radiosurgery System Market
16. UK Veterinary Stereotactic Radiosurgery System Market
17. Germany Veterinary Stereotactic Radiosurgery System Market
18. France Veterinary Stereotactic Radiosurgery System Market
19. Italy Veterinary Stereotactic Radiosurgery System Market
20. Spain Veterinary Stereotactic Radiosurgery System Market
21. Eastern Europe Veterinary Stereotactic Radiosurgery System Market
22. Russia Veterinary Stereotactic Radiosurgery System Market
23. North America Veterinary Stereotactic Radiosurgery System Market
24. USA Veterinary Stereotactic Radiosurgery System Market
25. Canada Veterinary Stereotactic Radiosurgery System Market
26. South America Veterinary Stereotactic Radiosurgery System Market
27. Brazil Veterinary Stereotactic Radiosurgery System Market
28. Middle East Veterinary Stereotactic Radiosurgery System Market
29. Africa Veterinary Stereotactic Radiosurgery System Market
30. Veterinary Stereotactic Radiosurgery System Market Competitive Landscape and Company Profiles
31. Veterinary Stereotactic Radiosurgery System Market Other Major and Innovative Companies
35. Veterinary Stereotactic Radiosurgery System Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Veterinary Stereotactic Radiosurgery System Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on veterinary stereotactic radiosurgery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary stereotactic radiosurgery system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary stereotactic radiosurgery system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Microsurgical Instrumentation; Optical or Viewing Instruments; Other Products2) by Modality: Gamma Knife; Linear Accelerator; Particle Beam Radiation Therapy; Cyber Knife
3) by Application: Canine; Feline; Other Applications
4) by End User: Hospitals; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) by Microsurgical Instrumentation: Stereotactic Frames; Navigation Systems; Targeting Devices2) by Optical or Viewing Instruments: Endoscopes; Surgical Microscopes; Imaging Systems
3) by Other Products: Treatment Planning Software; Radiation Delivery Systems; Accessories
Key Companies Mentioned: PetCure Oncology; Elekta AB; Accuray Incorporated; Varian Medical Systems Inc.; Nanovi Radiotherapy a/S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Veterinary Stereotactic Radiosurgery System market report include:- PetCure Oncology
- Elekta AB
- Accuray Incorporated
- Varian Medical Systems Inc.
- Nanovi Radiotherapy A/S
- Ion Beam Applications SA
- ZAP Surgical Systems Inc.
- Brainlab AG
- Best Medical International Inc.
- Mevion Medical Systems Inc.
- Hitachi Ltd.
- Sumitomo Heavy Industries Ltd.
- Shinva Medical Instrument Co. Ltd.
- Beijing Wandong Medical Equipment Co. Ltd.
- Neusoft Medical Systems Co. Ltd.
- Xinjiang Xinxing Medical Equipment Co. Ltd.
- Beijing Neusoft Medical Systems Co. Ltd.
- Siemens Healthineers AG
- Philips Healthcare Company
- GE Healthcare Technologies Inc.
- Toshiba Medical Systems Corporation
- Hitachi Aloka Medical Ltd.
- Vision RT Limited
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | February 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 3.28 Billion |
Forecasted Market Value ( USD | $ 5.28 Billion |
Compound Annual Growth Rate | 12.6% |
Regions Covered | Global |
No. of Companies Mentioned | 23 |